Profiel
Paul Rivard is currently the VP-Operations & General Counsel at MyMD Pharmaceuticals (Florida), Inc. Previously, he held the position of President & General Counsel at MIRA Pharmaceuticals, Inc. He also served as the Chief Legal Officer & Vice President-Operations at TNF Pharmaceuticals, Inc. from 2021 to 2023.
Mr. Rivard completed his undergraduate degree at Clarkson University in 1992 and obtained his graduate degree from Columbus School of Law in 1998.
Actieve functies van Paul Rivard
| Bedrijven | Functie | Begin |
|---|---|---|
MyMD Pharmaceuticals (Florida), Inc.
MyMD Pharmaceuticals (Florida), Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company that develops therapeutic platforms | Operationeel Directeur | - |
Eerdere bekende functies van Paul Rivard
| Bedrijven | Functie | Einde |
|---|---|---|
| Q/C TECHNOLOGIES, INC. | Operationeel Directeur | 14-11-2023 |
| MIRA PHARMACEUTICALS, INC. | President | - |
Opleiding van Paul Rivard
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Clarkson University
Clarkson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbus School of Law
Columbus School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MyMD Pharmaceuticals (Florida), Inc.
MyMD Pharmaceuticals (Florida), Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company that develops therapeutic platforms | Health Technology |
MyMD Pharmaceuticals, Inc.
MyMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that engages in the development of drug products to extend healthy lifespan | Health Technology |
MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells new molecular synthetic THC for the treatment of adult patients with anxiety and cognitive decline | Health Technology |
















